Fox Run Management, L.L.C. Inovio Pharmaceuticals, Inc. Transaction History

Fox Run Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$2.97 - $5.2 $55,794 - $97,687	-18,786 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$4.99 - $7.46 $38,338 - $57,315	7,683 Added 69.2%	18,786 $94,000
Q3 2021 Nov 15, 2021	BUY	$7.16 - $9.69 $79,497 - $107,588	11,103 New	11,103 $79,000
Q1 2019 Oct 17, 2019	SELL	$3.34 - $5.1 $48,313 - $73,771	-14,465 Closed	0 $0
Q4 2018 Jan 15, 2019	BUY	$3.89 - $6.11 $56,268 - $88,381	14,465 New	14,465 $58,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $536M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.